Denali Therap
DNLI23.0205.46% ( -1.330 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Denali Therap(DNLI) predict that the Revenue is 0 (--%), Miss estimate;the EBIT is -137.36 M (+5.65%), Miss estimate;the EPS is -0.69 (+11.54%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.00B--
-0.00B--%
EBITMiss expectations
-0.14B5.65%
-0.14B6.66%
-0.00B1.01%
EPSExceed expectations
-0.6911.54%
-0.71568.26%
+0.02563.28%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue2.192 M
Estimate EBIT-141.15 M
Estimate EPS-0.5651
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf